Developer docs
API playgroundTry for free, no card

Search company profiles

ProteoGenex

Full company profile

uuid000o919

Namestring
ProteoGenex
Legal namestring
ProteoGenex, Inc.
Websiteurl
proteogenex.com
Company typeenum
Private
Founded yearint
2003
Descriptiontext

ProteoGenex is a privately held US biospecimen and clinical-information provider founded in 2003 in Los Angeles (now headquartered in Inglewood, CA). The company operates a centralized biorepository of over 450,000 unique specimens — and more than 800,000 collected cumulatively over 20+ years — spanning fresh frozen tissues, FFPE tissues, blood products, biofluids, bone marrow/PBMCs, RNA/DNA, FDA Tissue Panels, matched tumor/normal pairs, and single-cell suspensions, with coverage across 450+ disease indications in Oncology, Dermatology, Neurology, Immunology, Infectious Diseases, Autoimmune, and Metabolic Disorders. Every specimen is accompanied by extensive clinical and pathological metadata including diagnosis, grade, TNM staging, biomarker status, treatment history, and up to five years of follow-up, with quality enforced through RIN≥7 RNA integrity checks, H&E pathology review by certified pathologists, and ≥60% tumor content thresholds.

The company's revenue model mixes transactional catalog sales of pre-collected specimens with higher-value custom services. Inventory sales operate on per-specimen, pay-as-you-go pricing across a range of tissue, blood, biofluid, and nucleic-acid formats. Custom Collections — a multi-year professional services offering — covers prospective specimen procurement with project management, custom protocol and Informed Consent Form development, site monitoring, and longitudinal study support. Tissue Microarray (TMA) construction (up to 300 cores per block in 0.6mm, 1mm, or 2mm sizes) and Human Single-Cell Suspension services extend the custom-service line into biomarker-screening and single-cell genomics workflows. A wholly-owned sister company, DxBiosamples, extends US tissue collection capacity.

ProteoGenex serves two primary B2B segments — pharmaceutical and biotechnology companies (drug discovery, companion diagnostics, clinical trial support, biomarker validation) and academic/government/non-profit research institutions (cancer research, proteomics, genomics, diagnostic assay development) — through direct enterprise sales organized by customer type, with dedicated phone/email channels for industry versus academia. Marketing relies on regular scientific conference presence (AACR, Molecular Medicine Tri-Conference, World Pharma Week), the company's publication footprint across hundreds of peer-reviewed papers, and a specimen-request-driven website funnel. All operations are conducted under IRB/IEC, HIPAA, GCP, and ICH compliance with WHO-aligned ethical standards.

Short descriptiontext

ProteoGenex is a privately held US biospecimen provider (founded 2003) operating a 450,000+ specimen biorepository across 450+ disease indications, serving pharmaceutical, biotechnology, and academic research customers with catalog specimens, custom prospective collections, tissue microarrays, and single-cell suspensions under full IRB/HIPAA compliance.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCulver City, United States
HQ citystring
Culver City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
human biospecimen supply, tissue specimen procurement, biorepository services, custom biospecimen collection, tissue microarray construction
Industry1 code
PRIMARYHLAGAEAI
Sample Logistics, Biorepository & IVD Kit Management (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Biobanking & Human Biospecimen Supply
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Biospecimen Sales (Inventory)
TypeOne Time License
Description

Direct sales of pre-collected human biological specimens from existing inventory including fresh frozen tissues, FFPE tissues, blood products, biofluids, and RNA/DNA. One-time transaction model with per-specimen pricing.

proteogenex.com
2Custom Collection Services
TypeProfessional Services
Description

Prospective specimen collection services tailored to specific research requirements. Includes project management, site monitoring, protocol development, and custom Informed Consent Form development. Long-term study support with diagnosis through treatment and beyond.

proteogenex.com
3Tissue Microarray (TMA) Services
TypeProfessional Services
Description

Custom-built TMA blocks for target expression and biomarker analysis. Core sizes 0.6mm, 1mm, 2mm; up to 300 cores per block. Slides cut and prepared from TMA blocks with H&E images provided.

proteogenex.com
4Single-Cell Suspension Services
TypeProfessional Services
Description

Isolation of primary cells from fresh tissues using collagenase digestion. Approximately 1x10^7 cells per tissue specimen, stored in vapor phase liquid nitrogen.

proteogenex.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D
Pricing details3 tiers
1Inventory Specimens
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Pre-collected specimens from existing inventory with standard specifications. Pricing varies by specimen type (tissue, blood, biofluid, RNA/DNA), disease state, and volume.

proteogenex.com
2Custom Collections
ModelOtherBilling cadenceMulti-year contract
Notes

Tailored prospective specimen collection based on exact research needs. Pricing includes estimated accrual rates, logistic analysis, and project management. Requires consultation with sales team.

proteogenex.com
3Tissue Microarray (TMA)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Custom TMA blocks with pricing based on number of cores, core size, and clinical data requirements. Includes detailed tissue core mapping and follow-up information where available.

proteogenex.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

ProteoGenex provides ethically sourced human biological specimens—fresh frozen tissues, FFPE tissues, FDA Tissue Panels, blood products (whole blood, serum, plasma), viable BMMCs/PBMCs, biofluids, and RNA/DNA—from a centralized biorepository of 450,000+ unique specimens. The company also delivers custom specimen collection services, custom-design tissue microarray (TMA) blocks, and human single-cell suspensions, all accompanied by extensive clinical and pathological data and verified through a stringent quality control program.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

ProteoGenex is an established provider of human biological specimens and clinical information, operating a centralized biorepository with over 450,000 specimens. The portfolio consists of the core Biorepository product offering various specimen types (fresh frozen tissues, FFPE tissues, blood products, biofluids, RNA/DNA, BM/PBMCs), complemented by Custom Services (Custom Collections, Tissue Microarrays, Human Single-Cell Suspensions) and a Quality Control Program. The Biorepository serves as the foundational inventory, while Custom Services enable prospective collection and custom-designed tissue-based research solutions. All products are supported by extensive pathology information and patient clinical history documentation.

Product and service11 records
1Biorepository (centralized specimen catalog)
CategoryHuman biospecimens / biorepository
Description

Centralized inventory of 450,000+ human clinical specimens including frozen and FFPE tissues, blood products, biofluids, bone marrow, PBMCs, and RNA/DNA, covering disease targets in Oncology, Hematology, Neurology, Immunology, Infectious Diseases, and other clinical areas. Sold to pharmaceutical, biotechnology, and academic researchers.

2Fresh Frozen Tissues
CategoryHuman biospecimens / tissue
Description

Snap-frozen human tissue specimens collected under IRB approval by certified medical pathologists, stored in vapor-phase liquid nitrogen at -190°C, with standard sample weight 0.5-1.0 gram and RNA Integrity Number (RIN) of 7 or higher. Available for oncology, neurology, immunology, and other research use.

3Formalin-Fixed Paraffin-Embedded (FFPE) Tissues
CategoryHuman biospecimens / tissue
Description

FFPE tissue specimens fixed in 10% Neutral-Buffered Formalin within 30-60 minutes of surgery and embedded in IHC-grade paraffin, stored at room temperature with detailed clinical and pathological information. Designed for IHC, ISH, and molecular pathology research applications.

4FDA Tissue Panel
CategoryHuman biospecimens / tissue panels
Description

Full FDA Panel of high-quality normal tissues for antibody cross-reactivity studies, available in fresh frozen and FFPE formats with clinical data including age, gender, ethnicity, and collection information. Targeted at antibody developers and diagnostic assay developers.

5Whole Blood, Serum, and Plasma
CategoryHuman biospecimens / blood products
Description

Blood products collected from normal and diseased donors: whole blood (up to 40 mL per donor), serum (~10-12 mL per draw), and plasma (~12-15 mL per draw), processed within 4 hours of collection and stored at -80°C. Used for biomarker, serology, and clinical research.

6Bone Marrow Mononuclear Cells (BMMCs) & Peripheral Blood Mononuclear Cells (PBMCs)
CategoryHuman biospecimens / viable cells
Description

Viable bone marrow mononuclear cells and peripheral blood mononuclear cells with at least 95% viability at freezing, stored and shipped in vapor-phase liquid nitrogen at -190°C. Designed for immunology, cell-therapy, and immune-monitoring research.

7Biofluids
CategoryHuman biospecimens / biofluids
Description

Biofluid specimens including urine, stool, ascites fluid, saliva, sputum, synovial fluid, and cerebrospinal fluid (CSF) collected from normal and diseased donors under IRB approval. Used for metabolomics, microbiome, and biomarker research.

8RNA & DNA
CategoryHuman biospecimens / nucleic acids
Description

Genetic derivatives (RNA and DNA) extracted from human tissues and biological fluids, with RNA specimens analyzed for integrity using the Agilent 2100 Bioanalyzer and stored in vapor-phase liquid nitrogen. Sold for genomics, transcriptomics, and molecular biology research.

9Custom Collections (Prospective Specimen Collection Services)
CategoryCustom biospecimen services / prospective collection
Description

Custom specimen collection services tailored to specific research requirements, including project management, custom protocol development, clinical site training, custom Informed Consent Form development, and longitudinal study support from diagnosis through treatment and beyond. Sold to pharmaceutical/biotech programs and academic investigators needing prospective or matched-donor collections.

10Tissue Microarray (TMA) Blocks
CategoryCustom biospecimen services / tissue microarray construction
Description

Custom-designed TMAs for target expression and biomarker analysis using carefully selected donors' FFPE tissues, with core sizes of 0.6 mm, 1 mm, and 2 mm and up to 300 cores per block (0.6 mm). Includes detailed tissue-core maps linking each core to clinical information, H&E images, and follow-up data where available. Sold to pharma, biotech, and academic researchers running high-throughput tissue studies.

11Human Single-Cell Suspensions
CategoryCustom biospecimen services / single-cell preparation
Description

Isolated primary human cells from fresh tissues (solid tumors and normal tissues) prepared via collagenase digestion, yielding approximately 1×10⁷ cells per tissue specimen, stored in vapor-phase liquid nitrogen. Designed for single-cell genomics, cell-therapy research, and downstream cellular assay applications.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Sister company providing tissue specimen collection services in the United States. ProteoGenex refers custom tissue collection requests to DxBiosamples, expanding their collective collection network and capabilities for prospective specimen procurement.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Human biospecimen CRO specializing in prospective collection of tissues, blood, and biofluids under IRB-approved protocols with detailed clinical data. Comparable to ProteoGenex's custom collections and longitudinal offerings, with similar disease-area breadth.

2Tissue Solutions
TypeDirect peer
Description

UK-based provider of ethically sourced human tissue and biofluid samples with global distribution to pharma and academic clients. Directly comparable on custom and catalog biospecimen procurement, though operating primarily from a European base.

TypeDirect peer
Description

Integrated biospecimen and bioservices provider offering tissue, blood, and cell products plus custom collections, flow cytometry, and molecular services. Overlaps heavily with ProteoGenex in biospecimen catalog and custom procurement, with broader downstream service capabilities.

TypeDirect peer
Description

One of the largest global providers of human biospecimens, including fresh frozen tissues, FFPE, blood products, and biofluids for pharma and academic research. Directly competes with ProteoGenex on catalog inventory, custom collections, and disease-area coverage, but at significantly greater scale and multi-site footprint.

TypeDirect peer
Description

Supplier of human tissue specimens, RNA/DNA derivatives, and protein products for research and diagnostic development. Overlaps with ProteoGenex's catalog offerings in FFPE tissues and nucleic acid derivatives for pharma and academic use.

TypeEmerging player
Description

Marketplace platform connecting researchers to a federated network of human biospecimen providers. Represents an alternative procurement model that could disintermediate traditional catalog providers like ProteoGenex by aggregating supply digitally.

TypeBroad incumbent
Description

Life science company offering biospecimens (including fresh and frozen tissues), primary cells, and iPSC-derived products for drug discovery. Broader portfolio than ProteoGenex, but overlaps on tissue procurement and custom human biological samples.

8Asterand Bioscience (now part of BioIVT)
TypeBroad incumbent
Description

Historically a direct peer in human tissue biospecimens, now absorbed into BioIVT's xPDC (Biospecimen) division. Referenced as a benchmark for the type of mid-sized competitor that has been consolidated into larger incumbents.

TypeDirect peer
Description

Provider of high-quality, clinically annotated human tissue samples and biofluids with a focus on oncology research. Competes with ProteoGenex on premium, annotated biospecimens and custom oncology collections.

TypeEmerging player
Description

Provider of dried blood spot and volumetric sampling technologies used in biospecimen collection and biobanking. Adjacent rather than directly competitive, but relevant as an enabling technology provider in the broader human biospecimen ecosystem.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ProteoGenex

Biobanking & Human Biospecimen Supplyproteogenex.com

ProteoGenex is a privately held US biospecimen provider (founded 2003) operating a 450,000+ specimen biorepository across 450+ disease indications, serving pharmaceutical, biotechnology, and academic research customers with catalog specimens, custom prospective collections, tissue microarrays, and single-cell suspensions under full IRB/HIPAA compliance.

What ProteoGenex does

ProteoGenex is a privately held US biospecimen and clinical-information provider founded in 2003 in Los Angeles (now headquartered in Inglewood, CA). The company operates a centralized biorepository of over 450,000 unique specimens — and more than 800,000 collected cumulatively over 20+ years — spanning fresh frozen tissues, FFPE tissues, blood products, biofluids, bone marrow/PBMCs, RNA/DNA, FDA Tissue Panels, matched tumor/normal pairs, and single-cell suspensions, with coverage across 450+ disease indications in Oncology, Dermatology, Neurology, Immunology, Infectious Diseases, Autoimmune, and Metabolic Disorders. Every specimen is accompanied by extensive clinical and pathological metadata including diagnosis, grade, TNM staging, biomarker status, treatment history, and up to five years of follow-up, with quality enforced through RIN≥7 RNA integrity checks, H&E pathology review by certified pathologists, and ≥60% tumor content thresholds.

The company's revenue model mixes transactional catalog sales of pre-collected specimens with higher-value custom services. Inventory sales operate on per-specimen, pay-as-you-go pricing across a range of tissue, blood, biofluid, and nucleic-acid formats. Custom Collections — a multi-year professional services offering — covers prospective specimen procurement with project management, custom protocol and Informed Consent Form development, site monitoring, and longitudinal study support. Tissue Microarray (TMA) construction (up to 300 cores per block in 0.6mm, 1mm, or 2mm sizes) and Human Single-Cell Suspension services extend the custom-service line into biomarker-screening and single-cell genomics workflows. A wholly-owned sister company, DxBiosamples, extends US tissue collection capacity.

ProteoGenex serves two primary B2B segments — pharmaceutical and biotechnology companies (drug discovery, companion diagnostics, clinical trial support, biomarker validation) and academic/government/non-profit research institutions (cancer research, proteomics, genomics, diagnostic assay development) — through direct enterprise sales organized by customer type, with dedicated phone/email channels for industry versus academia. Marketing relies on regular scientific conference presence (AACR, Molecular Medicine Tri-Conference, World Pharma Week), the company's publication footprint across hundreds of peer-reviewed papers, and a specimen-request-driven website funnel. All operations are conducted under IRB/IEC, HIPAA, GCP, and ICH compliance with WHO-aligned ethical standards.

ProteoGenex firmographics

Firmographics
Name
ProteoGenex
Legal name
ProteoGenex, Inc.
Website
https://proteogenex.com
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
1–10 employees
Short description
ProteoGenex is a privately held US biospecimen provider (founded 2003) operating a 450,000+ specimen biorepository across 450+ disease indications, serving pharmaceutical, biotechnology, and academic research customers with catalog specimens, custom prospective collections, tissue microarrays, and single-cell suspensions under full IRB/HIPAA compliance.
Ownership category
akta.pro rank

ProteoGenex industry classification

Industry
Product category
Biobanking & Human Biospecimen Supply
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAGAEAI
Sample Logistics, Biorepository & IVD Kit Management (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Human biospecimen supply
  • Tissue specimen procurement
  • Biorepository services
  • Custom biospecimen collection
  • Tissue microarray construction

Where ProteoGenex is headquartered

Location

Headquarters

HQ city
Culver City
HQ country
United States
HQ region
North America

Offices2 records

Markets served

ProteoGenex business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

  1. Biospecimen Sales (Inventory): Direct sales of pre-collected human biological specimens from existing inventory including fresh frozen tissues, FFPE tissues, blood products, biofluids, and RNA/DNA. One-time transaction model with per-specimen pricing.
  2. Custom Collection Services: Prospective specimen collection services tailored to specific research requirements. Includes project management, site monitoring, protocol development, and custom Informed Consent Form development. Long-term study support with diagnosis through treatment and beyond.
  3. Tissue Microarray (TMA) Services: Custom-built TMA blocks for target expression and biomarker analysis. Core sizes 0.6mm, 1mm, 2mm; up to 300 cores per block. Slides cut and prepared from TMA blocks with H&E images provided.
  4. Single-Cell Suspension Services: Isolation of primary cells from fresh tissues using collagenase digestion. Approximately 1x10^7 cells per tissue specimen, stored in vapor phase liquid nitrogen.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goInventory Specimens
OtherMulti-year contractCustom Collections
Unit PricingPay-as-you-goTissue Microarray (TMA)

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

ProteoGenex product offering

Product offering

Core offering

ProteoGenex provides ethically sourced human biological specimens—fresh frozen tissues, FFPE tissues, FDA Tissue Panels, blood products (whole blood, serum, plasma), viable BMMCs/PBMCs, biofluids, and RNA/DNA—from a centralized biorepository of 450,000+ unique specimens. The company also delivers custom specimen collection services, custom-design tissue microarray (TMA) blocks, and human single-cell suspensions, all accompanied by extensive clinical and pathological data and verified through a stringent quality control program.

Product overview

ProteoGenex is an established provider of human biological specimens and clinical information, operating a centralized biorepository with over 450,000 specimens. The portfolio consists of the core Biorepository product offering various specimen types (fresh frozen tissues, FFPE tissues, blood products, biofluids, RNA/DNA, BM/PBMCs), complemented by Custom Services (Custom Collections, Tissue Microarrays, Human Single-Cell Suspensions) and a Quality Control Program. The Biorepository serves as the foundational inventory, while Custom Services enable prospective collection and custom-designed tissue-based research solutions. All products are supported by extensive pathology information and patient clinical history documentation.

Differentiator

Problem solved

Functional benefit

Products and services

  • Biorepository (centralized specimen catalog) Centralized inventory of 450,000+ human clinical specimens including frozen and FFPE tissues, blood products, biofluids, bone marrow, PBMCs, and RNA/DNA, covering disease targets in Oncology, Hematology, Neurology, Immunology, Infectious Diseases, and other clinical areas. Sold to pharmaceutical, biotechnology, and academic researchers.
  • Fresh Frozen Tissues Snap-frozen human tissue specimens collected under IRB approval by certified medical pathologists, stored in vapor-phase liquid nitrogen at -190°C, with standard sample weight 0.5-1.0 gram and RNA Integrity Number (RIN) of 7 or higher. Available for oncology, neurology, immunology, and other research use.
  • Formalin-Fixed Paraffin-Embedded (FFPE) Tissues FFPE tissue specimens fixed in 10% Neutral-Buffered Formalin within 30-60 minutes of surgery and embedded in IHC-grade paraffin, stored at room temperature with detailed clinical and pathological information. Designed for IHC, ISH, and molecular pathology research applications.
  • FDA Tissue Panel Full FDA Panel of high-quality normal tissues for antibody cross-reactivity studies, available in fresh frozen and FFPE formats with clinical data including age, gender, ethnicity, and collection information. Targeted at antibody developers and diagnostic assay developers.
  • Whole Blood, Serum, and Plasma Blood products collected from normal and diseased donors: whole blood (up to 40 mL per donor), serum (~10-12 mL per draw), and plasma (~12-15 mL per draw), processed within 4 hours of collection and stored at -80°C. Used for biomarker, serology, and clinical research.
  • Bone Marrow Mononuclear Cells (BMMCs) & Peripheral Blood Mononuclear Cells (PBMCs) Viable bone marrow mononuclear cells and peripheral blood mononuclear cells with at least 95% viability at freezing, stored and shipped in vapor-phase liquid nitrogen at -190°C. Designed for immunology, cell-therapy, and immune-monitoring research.
  • Biofluids Biofluid specimens including urine, stool, ascites fluid, saliva, sputum, synovial fluid, and cerebrospinal fluid (CSF) collected from normal and diseased donors under IRB approval. Used for metabolomics, microbiome, and biomarker research.
  • RNA & DNA Genetic derivatives (RNA and DNA) extracted from human tissues and biological fluids, with RNA specimens analyzed for integrity using the Agilent 2100 Bioanalyzer and stored in vapor-phase liquid nitrogen. Sold for genomics, transcriptomics, and molecular biology research.
  • Custom Collections (Prospective Specimen Collection Services) Custom specimen collection services tailored to specific research requirements, including project management, custom protocol development, clinical site training, custom Informed Consent Form development, and longitudinal study support from diagnosis through treatment and beyond. Sold to pharmaceutical/biotech programs and academic investigators needing prospective or matched-donor collections.
  • Tissue Microarray (TMA) Blocks Custom-designed TMAs for target expression and biomarker analysis using carefully selected donors' FFPE tissues, with core sizes of 0.6 mm, 1 mm, and 2 mm and up to 300 cores per block (0.6 mm). Includes detailed tissue-core maps linking each core to clinical information, H&E images, and follow-up data where available. Sold to pharma, biotech, and academic researchers running high-throughput tissue studies.
  • Human Single-Cell Suspensions Isolated primary human cells from fresh tissues (solid tumors and normal tissues) prepared via collagenase digestion, yielding approximately 1×10⁷ cells per tissue specimen, stored in vapor-phase liquid nitrogen. Designed for single-cell genomics, cell-therapy research, and downstream cellular assay applications.

Companies that use ProteoGenex

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

ProteoGenex technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

ProteoGenex partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • DxBiosamplescoreStrategic or Co-development PartnerSister company providing tissue specimen collection services in the United States. ProteoGenex refers custom tissue collection requests to DxBiosamples, expanding their collective collection network and capabilities for prospective specimen procurement.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

ProteoGenex competitors and assessment

Company assessment

Direct peers

  • Cureline: Human biospecimen CRO specializing in prospective collection of tissues, blood, and biofluids under IRB-approved protocols with detailed clinical data. Comparable to ProteoGenex's custom collections and longitudinal offerings, with similar disease-area breadth.
  • Tissue Solutions: UK-based provider of ethically sourced human tissue and biofluid samples with global distribution to pharma and academic clients. Directly comparable on custom and catalog biospecimen procurement, though operating primarily from a European base.
  • Discovery Life Sciences: Integrated biospecimen and bioservices provider offering tissue, blood, and cell products plus custom collections, flow cytometry, and molecular services. Overlaps heavily with ProteoGenex in biospecimen catalog and custom procurement, with broader downstream service capabilities.
  • BioIVT: One of the largest global providers of human biospecimens, including fresh frozen tissues, FFPE, blood products, and biofluids for pharma and academic research. Directly competes with ProteoGenex on catalog inventory, custom collections, and disease-area coverage, but at significantly greater scale and multi-site footprint.
  • BioChain Institute: Supplier of human tissue specimens, RNA/DNA derivatives, and protein products for research and diagnostic development. Overlaps with ProteoGenex's catalog offerings in FFPE tissues and nucleic acid derivatives for pharma and academic use.
  • Indivumed: Provider of high-quality, clinically annotated human tissue samples and biofluids with a focus on oncology research. Competes with ProteoGenex on premium, annotated biospecimens and custom oncology collections.

Emerging players

  • iSpecimen: Marketplace platform connecting researchers to a federated network of human biospecimen providers. Represents an alternative procurement model that could disintermediate traditional catalog providers like ProteoGenex by aggregating supply digitally.
  • Capitainer: Provider of dried blood spot and volumetric sampling technologies used in biospecimen collection and biobanking. Adjacent rather than directly competitive, but relevant as an enabling technology provider in the broader human biospecimen ecosystem.

Broad incumbents

  • ReproCELL: Life science company offering biospecimens (including fresh and frozen tissues), primary cells, and iPSC-derived products for drug discovery. Broader portfolio than ProteoGenex, but overlaps on tissue procurement and custom human biological samples.
  • Asterand Bioscience (now part of BioIVT): Historically a direct peer in human tissue biospecimens, now absorbed into BioIVT's xPDC (Biospecimen) division. Referenced as a benchmark for the type of mid-sized competitor that has been consolidated into larger incumbents.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

ProteoGenex social profiles

Digital presence

ProteoGenex financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ProteoGenex leadership team

Management profile

Number of profiles

ProteoGenex subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

ProteoGenex funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ProteoGenex M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ProteoGenex

What does ProteoGenex do?

ProteoGenex provides ethically sourced human biological specimens—fresh frozen tissues, FFPE tissues, FDA Tissue Panels, blood products (whole blood, serum, plasma), viable BMMCs/PBMCs, biofluids, and RNA/DNA—from a centralized biorepository of 450,000+ unique specimens. The company also delivers custom specimen collection services, custom-design tissue microarray (TMA) blocks, and human single-cell suspensions, all accompanied by extensive clinical and pathological data and verified through a stringent quality control program.

Is ProteoGenex a public or private company?

ProteoGenex is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was ProteoGenex founded?

ProteoGenex was founded in 2003. It employs 1 to 10 people.

Where is ProteoGenex based?

ProteoGenex is headquartered in Culver City, United States, in the North America region.

How does ProteoGenex make money?

Four revenue lines are on record. Biospecimen Sales (Inventory) is the primary driver. The others are custom Collection Services, tissue Microarray (TMA) Services and single-Cell Suspension Services.

Who are ProteoGenex's main competitors?

Direct peers on record are Cureline, Tissue Solutions, Discovery Life Sciences, BioIVT, BioChain Institute and Indivumed. Emerging players are iSpecimen and Capitainer. Broad incumbents are ReproCELL and Asterand Bioscience (now part of BioIVT).

Does ProteoGenex have an API?

No public API is recorded for ProteoGenex.

What industry is ProteoGenex in?

ProteoGenex's product category is Biobanking & Human Biospecimen Supply. Its primary akta.pro industry code is HLAGAEAI, Sample Logistics, Biorepository & IVD Kit Management (Trial Support). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals